Indications

REBLOZYL is for adults with very low- to intermediate-risk of myelodysplastic (MDS) who may need regular red blood cell (RBC) transfusions and who have never received an erythropoiesis-stimulating agent (ESA)

AND

REBLOZYL is also for adults with MDS-RS or myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) who need RBC transfusions and have not responded well to or cannot receive an ESA.

 

Select (+) to find answers for some of the most commonly asked questions about the REBLOZYL experience

 

Is REBLOZYL right for me?

 

What should I know and expect when taking REBLOZYL?



swoosh

This website is intended for U.S. residents 18 years of age or older.

REBLOZYL® is a trademark of Celgene Corporation, a Bristol Myers Squibb company.

Access Support® and Your REBLOZYL Connection are trademarks of Bristol-Myers Squibb Company.

REBLOZYL® is licensed from Merck & Co. Inc., Rahway, NJ, USA and its affiliates.

© 2024 Bristol-Myers Squibb Company.

2007-US-2400432  11/24